Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABBV AbbVie	$217.83 -0.4%	$208.25	$181.73 ▼ $244.81	$384.85B	0.32	6.91 million shs	7.62 million shs
BRK.B Berkshire Hathaway	$474.61 -0.6%	$477.78	$455.18 ▼ $516.85	$1.02T	0.63	4.86 million shs	7.90 million shs
IYH iShares U.S. Healthcare ETF	$63.03 -0.8%	$61.54	$53.94 ▼ $67.63	$2.95B	0.59	784,611 shs	396,658 shs
JNJ Johnson & Johnson	$225.16 -2.4%	$233.26	$149.04 ▼ $251.71	$542.01B	0.27	8.41 million shs	13.90 million shs
LLY Eli Lilly and Company	$1,105.37 -1.9%	$952.15	$623.78 ▼ $1,149.10	$1.04T	0.48	3.21 million shs	4.60 million shs
MRK Merck & Co., Inc.	$118.49 -1.2%	$116.31	$75.40 ▼ $125.14	$292.66B	0.18	10.90 million shs	16.60 million shs
PLTR Palantir Technologies	$156.54 +9.2%	$141.62	$118.93 ▼ $207.52	$375.27B	1.52	48.51 million shs	91.98 million shs
UNH UnitedHealth Group	$379.70 -0.7%	$334.93	$234.60 ▼ $404.15	$344.82B	0.64	9.04 million shs	10.26 million shs

5G Stocks: The Path Forward is Profitable

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABBV AbbVie	+1.50%	+1.77%	+10.52%	-5.62%	+19.50%
BRK.B Berkshire Hathaway	-0.50%	-0.55%	-0.11%	-5.40%	-5.14%
IYH iShares U.S. Healthcare ETF	+1.47%	+1.97%	+5.18%	-4.97%	+15.57%
JNJ Johnson & Johnson	-0.15%	-0.29%	+1.47%	-7.15%	+51.46%
LLY Eli Lilly and Company	+3.81%	+8.14%	+28.89%	+7.26%	+56.79%
MRK Merck & Co., Inc.	-0.33%	+3.46%	+8.85%	-2.90%	+57.37%
PLTR Palantir Technologies	+8.17%	+4.32%	+1.48%	+4.48%	+15.82%
UNH UnitedHealth Group	-0.55%	-0.02%	+4.26%	+30.48%	+28.50%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABBV AbbVie	$217.83 -0.4%	$208.25	$181.73 ▼ $244.81	$384.85B	0.32	6.91 million shs	7.62 million shs
BRK.B Berkshire Hathaway	$474.61 -0.6%	$477.78	$455.18 ▼ $516.85	$1.02T	0.63	4.86 million shs	7.90 million shs
IYH iShares U.S. Healthcare ETF	$63.03 -0.8%	$61.54	$53.94 ▼ $67.63	$2.95B	0.59	784,611 shs	396,658 shs
JNJ Johnson & Johnson	$225.16 -2.4%	$233.26	$149.04 ▼ $251.71	$542.01B	0.27	8.41 million shs	13.90 million shs
LLY Eli Lilly and Company	$1,105.37 -1.9%	$952.15	$623.78 ▼ $1,149.10	$1.04T	0.48	3.21 million shs	4.60 million shs
MRK Merck & Co., Inc.	$118.49 -1.2%	$116.31	$75.40 ▼ $125.14	$292.66B	0.18	10.90 million shs	16.60 million shs
PLTR Palantir Technologies	$156.54 +9.2%	$141.62	$118.93 ▼ $207.52	$375.27B	1.52	48.51 million shs	91.98 million shs
UNH UnitedHealth Group	$379.70 -0.7%	$334.93	$234.60 ▼ $404.15	$344.82B	0.64	9.04 million shs	10.26 million shs

5G Stocks: The Path Forward is Profitable

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABBV AbbVie	+1.50%	+1.77%	+10.52%	-5.62%	+19.50%
BRK.B Berkshire Hathaway	-0.50%	-0.55%	-0.11%	-5.40%	-5.14%
IYH iShares U.S. Healthcare ETF	+1.47%	+1.97%	+5.18%	-4.97%	+15.57%
JNJ Johnson & Johnson	-0.15%	-0.29%	+1.47%	-7.15%	+51.46%
LLY Eli Lilly and Company	+3.81%	+8.14%	+28.89%	+7.26%	+56.79%
MRK Merck & Co., Inc.	-0.33%	+3.46%	+8.85%	-2.90%	+57.37%
PLTR Palantir Technologies	+8.17%	+4.32%	+1.48%	+4.48%	+15.82%
UNH UnitedHealth Group	-0.55%	-0.02%	+4.26%	+30.48%	+28.50%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABBV AbbVie	2.88	Moderate Buy	$253.43	16.34% Upside
BRK.B Berkshire Hathaway	2.33	Hold	$524.50	10.51% Upside
IYH iShares U.S. Healthcare ETF	2.75	Moderate Buy	$63.03	N/A
JNJ Johnson & Johnson	2.74	Moderate Buy	$253.04	12.38% Upside
LLY Eli Lilly and Company	2.87	Moderate Buy	$1,227.00	11.00% Upside
MRK Merck & Co., Inc.	2.68	Moderate Buy	$128.18	8.17% Upside
PLTR Palantir Technologies	2.61	Moderate Buy	$192.76	23.14% Upside
UNH UnitedHealth Group	2.74	Moderate Buy	$397.63	4.72% Upside

Current Analyst Ratings Breakdown

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/27/2026	UNH UnitedHealth Group	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$492.00
5/27/2026	UNH UnitedHealth Group	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$444.00 ➝ $492.00
5/26/2026	LLY Eli Lilly and Company	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$1,133.00 ➝ $1,251.00
5/26/2026	LLY Eli Lilly and Company	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$1,119.00
5/26/2026	UNH UnitedHealth Group	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$373.00 ➝ $429.00
5/22/2026	PLTR Palantir Technologies	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$138.00
5/22/2026	LLY Eli Lilly and Company	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$1,283.00
5/22/2026	UNH UnitedHealth Group	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$410.00 ➝ $460.00
5/21/2026	LLY Eli Lilly and Company	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$1,350.00
5/21/2026	LLY Eli Lilly and Company	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
5/21/2026	LLY Eli Lilly and Company	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target		$1,300.00 ➝ $1,330.00

(Data available from 5/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABBV AbbVie	$61.16B	6.29	$15.32 per share	14.22	($3.74) per share	-58.24
BRK.B Berkshire Hathaway	$419.30B	2.44	$26.57 per share	17.86	$338.20 per share	1.40
IYH iShares U.S. Healthcare ETF	N/A	N/A	N/A	N/A	N/A	N/A
JNJ Johnson & Johnson	$94.19B	5.75	$13.75 per share	16.38	$33.73 per share	6.68
LLY Eli Lilly and Company	$65.18B	15.97	$25.66 per share	43.08	$33.13 per share	33.36
MRK Merck & Co., Inc.	$65.01B	4.50	$11.25 per share	10.53	$18.60 per share	6.37
PLTR Palantir Technologies	$4.48B	83.85	$0.82 per share	191.90	$3.57 per share	43.85
UNH UnitedHealth Group	$447.57B	0.77	$21.02 per share	18.06	$114.40 per share	3.32

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABBV AbbVie	$4.23B	$2.03	107.30	13.36	0.74	5.79%	-576.45%	13.39%	7/30/2026 (Estimated)
BRK.B Berkshire Hathaway	$66.97B	$33.59	14.13	22.19	N/A	19.31%	6.55%	3.80%	N/A
IYH iShares U.S. Healthcare ETF	N/A	N/A	21.05	N/A	N/A	N/A	N/A	N/A	N/A
JNJ Johnson & Johnson	$26.80B	$8.65	26.03	17.90	2.27	21.83%	32.60%	13.29%	7/15/2026 (Estimated)
LLY Eli Lilly and Company	$20.64B	$28.15	39.27	24.94	1.18	34.98%	105.77%	23.76%	8/5/2026 (Estimated)
MRK Merck & Co., Inc.	$18.25B	$3.55	33.38	12.12	2.71	13.59%	27.55%	10.73%	8/4/2026 (Estimated)
PLTR Palantir Technologies	$1.63B	$0.89	175.89	93.18	2.10	43.67%	28.34%	23.57%	8/3/2026 (Estimated)
UNH UnitedHealth Group	$12.06B	$13.24	28.68	18.32	1.66	2.68%	14.65%	4.77%	8/4/2026 (Estimated)

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/4/2026	Q1 2026	PLTR Palantir Technologies	$0.2774	$0.33	+$0.0526	$0.34	$1.54 billion	$1.63 billion
5/2/2026	Q1 2026	BRK.B Berkshire Hathaway	$4.82	$5.25	+$0.43	$5.82	$95.10 billion	$93.68 billion
4/30/2026	Q1 2026	LLY Eli Lilly and Company	$6.97	$8.55	+$1.58	$8.26	$17.82 billion	$19.80 billion
4/30/2026	Q1 2026	MRK Merck & Co., Inc.	-$1.47	-$1.28	+$0.19	-$1.72	$15.85 billion	$16.29 billion
4/29/2026	Q1 2026	ABBV AbbVie	$2.59	$2.65	+$0.06	$0.39	$14.72 billion	$15.00 billion
4/21/2026	Q1 2026	UNH UnitedHealth Group	$6.76	$7.23	+$0.47	$6.90	$109.84 billion	$111.65 billion
4/14/2026	Q1 2026	JNJ Johnson & Johnson	$2.68	$2.70	+$0.02	$2.14	$23.60 billion	$24.06 billion
2/28/2026	Q4 2025	BRK.B Berkshire Hathaway	$5.19	$4.73	-$0.46	$0.56	$102.89 billion	$94.23 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABBV AbbVie	$6.92	3.18%	+6.80%	340.89%	53 Years
BRK.B Berkshire Hathaway	N/A	N/A	N/A	N/A	N/A
IYH iShares U.S. Healthcare ETF	$0.80	1.27%	N/A	N/A	N/A
JNJ Johnson & Johnson	$5.36	2.38%	+5.25%	61.97%	64 Years
LLY Eli Lilly and Company	$6.92	0.63%	+15.18%	24.58%	11 Years
MRK Merck & Co., Inc.	$3.40	2.87%	+5.75%	95.77%	14 Years
PLTR Palantir Technologies	N/A	N/A	N/A	N/A	N/A
UNH UnitedHealth Group	$8.84	2.33%	+12.57%	66.77%	15 Years

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/26/2026	MRK Merck & Co., Inc.	quarterly	$0.85	2.84%	6/15/2026	6/15/2026	7/8/2026
5/4/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.69%	5/15/2026	5/15/2026	6/10/2026
4/14/2026	JNJ Johnson & Johnson	quarterly	$1.34	2.33%	5/26/2026	5/26/2026	6/9/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABBV AbbVie	N/A	0.80	0.68
BRK.B Berkshire Hathaway	N/A	0.36	0.36
IYH iShares U.S. Healthcare ETF	N/A	N/A	N/A
JNJ Johnson & Johnson	0.46	1.03	0.77
LLY Eli Lilly and Company	1.26	1.50	1.10
MRK Merck & Co., Inc.	1.02	1.30	1.06
PLTR Palantir Technologies	N/A	6.91	6.91
UNH UnitedHealth Group	0.69	0.80	0.80

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABBV AbbVie	70.23%
BRK.B Berkshire Hathaway	39.25%
IYH iShares U.S. Healthcare ETF	N/A
JNJ Johnson & Johnson	69.55%
LLY Eli Lilly and Company	82.53%
MRK Merck & Co., Inc.	76.07%
PLTR Palantir Technologies	45.65%
UNH UnitedHealth Group	87.86%

Insider Ownership

Company	Insider Ownership
ABBV AbbVie	0.06%
BRK.B Berkshire Hathaway	6.05%
IYH iShares U.S. Healthcare ETF	N/A
JNJ Johnson & Johnson	0.16%
LLY Eli Lilly and Company	0.14%
MRK Merck & Co., Inc.	0.17%
PLTR Palantir Technologies	9.53%
UNH UnitedHealth Group	0.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABBV AbbVie	57,000	1.77 billion	1.77 billion	Optionable
BRK.B Berkshire Hathaway	387,800	2.16 billion	2.03 billion	Optionable
IYH iShares U.S. Healthcare ETF	N/A	46.75 million	N/A	Not Optionable
JNJ Johnson & Johnson	138,200	2.41 billion	2.40 billion	Optionable
LLY Eli Lilly and Company	50,000	941.74 million	940.42 million	Optionable
MRK Merck & Co., Inc.	75,000	2.47 billion	2.47 billion	Optionable
PLTR Palantir Technologies	4,429	2.40 billion	2.17 billion	Optionable
UNH UnitedHealth Group	390,000	908.14 million	905.60 million	Optionable

IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Headlines

Recent News About These Companies

UnitedHealth cuts nearly two-thirds of prior authorizations in pediatrics

4 hours ago | seekingalpha.com

Massachusetts sues UnitedHealth unit over alleged Medicaid fraud

4 hours ago | finance.yahoo.com

Here’s Why UnitedHealth (UNH) Slid in Q1

May 29 at 9:51 AM | insidermonkey.com

UnitedHealthcare Eliminates Nearly Two-Thirds of Prior Authorization Requirements for Pediatric Care

May 29 at 9:07 AM | finance.yahoo.com

UnitedHealth to Reduce Pediatric Prior Authorizations

May 29 at 8:20 AM | wsj.com

UnitedHealthcare to remove prior insurance approval requirements for nearly two-thirds of pediatric services

May 29 at 8:09 AM | reuters.com

UnitedHealthcare Reduces Most Prior Approvals For Pediatric Patients

May 29 at 8:00 AM | forbes.com

UnitedHealth Group Incorporated $UNH Stock Position Lifted by National Pension Service

May 29 at 6:37 AM | marketbeat.com

Linscomb Wealth Inc. Purchases 13,787 Shares of UnitedHealth Group Incorporated $UNH

May 29 at 6:29 AM | marketbeat.com

Inspire Trust Co. N.A. Grows Stake in UnitedHealth Group Incorporated $UNH

May 29 at 6:17 AM | marketbeat.com

Top Healthcare Stocks Worth Watching - May 26th

May 29 at 6:14 AM | americanbankingnews.com

Ilmarinen Mutual Pension Insurance Co Sells 23,300 Shares of UnitedHealth Group Incorporated $UNH

May 29 at 6:01 AM | marketbeat.com

Intech Investment Management LLC Raises Stock Position in UnitedHealth Group Incorporated $UNH

May 29 at 5:51 AM | marketbeat.com

King Luther Capital Management Corp Decreases Stock Holdings in UnitedHealth Group Incorporated $UNH

May 29 at 5:25 AM | marketbeat.com

Fideuram Asset Management Ireland dac Makes New Investment in UnitedHealth Group Incorporated $UNH

May 29 at 4:28 AM | marketbeat.com

Berkshire Exit Puts Spotlight On UnitedHealth Risks Rewards And Valuation

May 28 at 11:53 PM | finance.yahoo.com

UnitedHealth vs. Molina: Which Managed Care Stock Is the Better Bet?

May 28 at 6:53 PM | finance.yahoo.com

UnitedHealth Group Stock: Is UNH Outperforming the Healthcare Sector?

May 28 at 6:30 PM | barchart.com

UnitedHealth vs. Molina: Which Managed Care Stock Is the Better Bet?

May 28 at 2:21 PM | zacks.com

Is UnitedHealth set for a dividend hike? SA analysts weigh in

May 28 at 1:52 PM | seekingalpha.com

UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It

May 28 at 1:52 PM | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Company Descriptions

AbbVie NYSE:ABBV

$217.83 -0.80 (-0.37%)

Closing price 03:59 PM Eastern

Extended Trading

$217.50 -0.33 (-0.15%)

As of 06:46 PM Eastern

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Berkshire Hathaway NYSE:BRK.B

$474.61 -2.81 (-0.59%)

Closing price 03:59 PM Eastern

Extended Trading

$474.20 -0.40 (-0.08%)

As of 06:47 PM Eastern

Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. The company provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. It also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydroelectric, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, liquefied natural gas facilities, and compressor and meter stations; and holds interest in coal mining assets. In addition, the company manufactures boxed chocolates and other confectionery products; specialty chemicals, metal cutting tools, and components for aerospace and power generation applications; flooring products; insulation, roofing, and engineered products; building and engineered components; paints and coatings; and bricks and masonry products, as well as offers manufactured and site-built home construction, and related lending and financial services. Further, it provides recreational vehicles, apparel and footwear products, jewelry, and custom picture framing products, as well as alkaline batteries; castings, forgings, fasteners/fastener systems, aerostructures, and precision components; and cobalt, nickel, and titanium alloys. Additionally, the company distributes televisions and information; franchises and services quick service restaurants; distributes electronic components; and offers logistics services, grocery and foodservice distribution services, and professional aviation training and shared aircraft ownership programs. It also retails automobiles; furniture, bedding, and accessories; household appliances, electronics, and computers; jewelry, watches, crystal, china, stemware, flatware, gifts, and collectibles; kitchenware; and motorcycle clothing and equipment. The company was incorporated in 1998 and is headquartered in Omaha, Nebraska.

Extended Trading

$379.42 -0.27 (-0.07%)

As of 06:46 PM Eastern

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Earnings

Compare Dividends

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools